TherapeuticsMD Inc TXMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.01
- Day Range
- $1.95–2.06
- 52-Week Range
- $0.99–2.95
- Bid/Ask
- $1.91 / $2.05
- Shares Outstanding
- 11.57M
- Market Cap
- $23.15M
- Volume/Avg
- 13,180 / 39,350
Key Statistics
- Price/Earnings (Normalized)
- 155.39
- Price/Sales
- 6.81
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1
- Website
- https://www.therapeuticsmd.com
Valuation
|
Metric
|
TXMD
|
|---|---|
Price/Earnings (Normalized) | 155.39 |
Price/Book Value | 0.85 |
Price/Sales | 6.81 |
Price/Cash Flow | 15.25 |
Price/Earnings
TXMD
Financial Strength
|
Metric
|
TXMD
|
|---|---|
Quick Ratio | 2.50 |
Current Ratio | 3.11 |
Interest Coverage | — |
Quick Ratio
TXMD
Profitability
|
Metric
|
TXMD
|
|---|---|
Return on Assets (Normalized) | 0.50% |
Return on Equity (Normalized) | 0.70% |
Return on Invested Capital (Normalized) | 0.16% |
Return on Assets
TXMD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|bzzQv<^ | LOCK|Jk!p | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|n&<!Xkn | LOCK|@q | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|p@bL>F< | LOCK|?Hylt | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|#Vn>f$<& | LOCK|D? | $32B | |||
| Viatris Inc
VTRS
| LOCK|m^#$b! | LOCK|s& | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|zn | LOCK|d! | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|X%#Dhr | LOCK|D& | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|%%F<wJ? | LOCK|SC$ | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|bY#%Sr? | LOCK|<<&t | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|K$@$vJs | LOCK|wV | $1B |
United States